These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19301123)

  • 1. Population ageing and its implications on aggregate health care demand: empirical evidence from 22 OECD countries.
    Palangkaraya A; Yong J
    Int J Health Care Finance Econ; 2009 Dec; 9(4):391-402. PubMed ID: 19301123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care expenditure in the last months of life.
    Felder S; Meier M; Schmitt H
    J Health Econ; 2000 Sep; 19(5):679-95. PubMed ID: 11184799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population ageing and health care expenditure: a school of 'red herrings'?
    Werblow A; Felder S; Zweifel P
    Health Econ; 2007 Oct; 16(10):1109-26. PubMed ID: 17311357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An econometric analysis of health care expenditure: a cross-section study of the OECD countries.
    Gerdtham UG; Søgaard J; Andersson F; Jönsson B
    J Health Econ; 1992 May; 11(1):63-84. PubMed ID: 10119757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. It's not ageing, stupid: why population ageing won't bankrupt health systems.
    Jayawardana S; Cylus J; Mossialos E
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):195-201. PubMed ID: 31050714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing and health-care expenditure: the red herring argument revisited.
    Seshamani M; Gray A
    Health Econ; 2004 Apr; 13(4):303-14. PubMed ID: 15067669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroeconomic implications of population ageing and selected policy responses.
    Bloom DE; Chatterji S; Kowal P; Lloyd-Sherlock P; McKee M; Rechel B; Rosenberg L; Smith JP
    Lancet; 2015 Feb; 385(9968):649-657. PubMed ID: 25468167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population ageing and mortality during 1990-2017: A global decomposition analysis.
    Cheng X; Yang Y; Schwebel DC; Liu Z; Li L; Cheng P; Ning P; Hu G
    PLoS Med; 2020 Jun; 17(6):e1003138. PubMed ID: 32511229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute hospital sector in selected OECD countries: an analysis of expenditure and utilization.
    Wiley MM
    World Hosp Health Serv; 1996; 32(1):5-13. PubMed ID: 10172701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants of health expenditure in the OECD countries: a pooled data analysis.
    Gerdtham UG; Jönsson B; MacFarlan M; Oxley H
    Dev Health Econ Public Policy; 1998; 6():113-34. PubMed ID: 10662400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis.
    Colombier C; Weber W
    Int J Health Plann Manage; 2011; 26(3):246-63. PubMed ID: 20939027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal costs, improved life expectancy and future public health expenditure.
    Bjørner TB; Arnberg S
    Int J Health Care Finance Econ; 2012 Jun; 12(2):129-43. PubMed ID: 22407513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.
    Moore PV; Bennett K; Normand C
    Appl Health Econ Health Policy; 2014 Dec; 12(6):623-33. PubMed ID: 25141830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageing and healthcare expenditures: Exploring the role of individual health status.
    Carreras M; Ibern P; Inoriza JM
    Health Econ; 2018 May; 27(5):865-876. PubMed ID: 29424031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investing preventive care and economic development in ageing societies: empirical evidences from OECD countries.
    Wang F; Wang JD
    Health Econ Rev; 2021 Jun; 11(1):18. PubMed ID: 34086126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of population ageing on health care expenditure: A Bayesian VAR analysis using data from Italy.
    Lopreite M; Mauro M
    Health Policy; 2017 Jun; 121(6):663-674. PubMed ID: 28392027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmet medical needs in ambulatory care in Hungary: forgone visits and medications from a representative population survey.
    Lucevic A; Péntek M; Kringos D; Klazinga N; Gulácsi L; Brito Fernandes Ó; Boncz I; Baji P
    Eur J Health Econ; 2019 Jun; 20(Suppl 1):71-78. PubMed ID: 31102157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.